Twist Bioscience CEO Emily Leproust sells $919,373 in stock

Twist Bioscience CEO Emily Leproust sold 4,548 shares of the company's common stock on October 5, 2026, for a total of $919,373, according to an SEC Form 4 filing. The sale was made under a Rule 10b5-1 trading plan adopted in June 2026. Since the transaction, the stock price has declined, currently trading at $159.78, down 15% from the previous week, despite a remarkable 412% return over the last year. Following the sale, Leproust directly holds 562,760 shares of Twist Bioscience common stock.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.